Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;459(1):81-9.
doi: 10.1007/s00428-011-1091-0. Epub 2011 May 29.

Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases

Christoph Köhler  1
Affiliations

Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases

Christoph Köhler. Virchows Arch. 2011 Jul.

Abstract

Alternative splicing of the caldesmon gene results in high (h-caldesmon) and low (l-caldesmon) molecular weight isoforms of the cytoskeleton-associated protein caldesmon. h-Caldesmon is predominantly expressed not only in smooth-muscle cells but also in pericryptal fibroblasts in colon. l-Caldesmon is widely expressed and localized in podosomes/invadopodia. Studies with transformed and cancer cell lines suggest that a reduction in l-caldesmon facilitates podosome/invadopodia formation and metastasis. We investigated caldesmon isoforms in colon adenocarcinoma and their lymph node metastases using immunohistochemistry. Caldesmon immunoreactivity of colon adenocarcinoma primary tumors and lymph node metastases was very similar. l-Caldesmon immunoreactivity of cancer epithelial cells in primary tumors and lymph node metastases varied ranging from reduced to stronger as compared to immunoreactivity of normal areas. The variation did not show a consistent relation to the tumor center or invasive margin. While h-caldesmon immunoreactivity of pericryptal fibroblasts and blood vessels in the stroma of primary tumors and lymph node metastases was markedly reduced, cancer-associated fibroblasts and blood vessels in the stroma were strongly immunoreactive for l-caldesmon. Our results show a differential behavior of h- and l-caldesmon isoforms in epithelium and stroma of colon adenocarcinoma and lymph node metastases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. J Biol Chem. 1991 Sep 5;266(25):16917-24 - PubMed
    1. Oncology. 2005;69 Suppl 1:14-6 - PubMed
    1. Mod Pathol. 1999 Aug;12(8):756-62 - PubMed
    1. Mod Pathol. 2009 May;22(5):639-50 - PubMed
    1. J Histochem Cytochem. 2010 Feb;58(2):183-93 - PubMed

LinkOut - more resources